(Q51475379)

5 April 2018

title

ADMA is independently related to flow-mediated vasodilation in subjects at low cardiovascular risk. (English)

1 reference

5 April 2018

1 reference

7

G M Reaven

1 reference

5 April 2018

D Ardigo

1

1 reference

5 April 2018

M Stüehlinger

2

1 reference

5 April 2018

L Franzini

3

1 reference

5 April 2018

S Valtueña

4

1 reference

5 April 2018

P M Piatti

5

1 reference

5 April 2018

O Pachinger

6

1 reference

5 April 2018

I Zavaroni

8

1 reference

5 April 2018

publication date

1 April 2007

1 reference

5 April 2018

European Journal of Clinical Investigation

published in

1 reference

5 April 2018

volume

37

1 reference

5 April 2018

issue

4

1 reference

5 April 2018

page(s)

263-269

1 reference

5 April 2018

Prognostic significance of endothelial dysfunction in hypertensive patients

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01781.X

Biological significance of endogenous methylarginines that inhibit nitric oxide synthases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01781.X

Association of asymmetric dimethylarginine and endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01781.X

Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01781.X

Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01781.X

Effect of diabetic duration on serum concentrations of endogenous inhibitor of nitric oxide synthase in patients and rats with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01781.X

Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01781.X

Reduced urinary excretion of nitric oxide metabolites and increased plasma levels of asymmetric dimethylarginine in men with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01781.X

Plasma asymmetric dimethylarginine concentrations in newly diagnosed patients with acute myocardial infarction or unstable angina pectoris during two weeks of medical treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01781.X

Elevation of asymmetric dimethylarginine in patients with unstable angina and recurrent cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01781.X

Elevated levels of plasma homocyst(e)ine and asymmetric dimethylarginine in elderly patients with stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01781.X

Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01781.X

Hyperinsulinemia in a normal population as a predictor of non-insulin-dependent diabetes mellitus, hypertension, and coronary heart disease: the Barilla factory revisited.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01781.X

Prediction of Coronary Heart Disease Using Risk Factor Categories

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01781.X

Hyperinsulinemia predicts hepatic fat content in healthy individuals with normal transaminase concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01781.X

Relation of plasma insulin levels to forearm flow-mediated dilatation in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01781.X

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01781.X

Total antioxidant capacity of the diet is inversely and independently related to plasma concentration of high-sensitivity C-reactive protein in adult Italian subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01781.X

Cardiovascular effects of systemic nitric oxide synthase inhibition with asymmetrical dimethylarginine in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01781.X

Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01781.X

Asymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease: results from the AtheroGene Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01781.X

Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01781.X

Influence of vessel size, age and body mass index on the flow-mediated dilatation (FMD%) of the brachial artery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01781.X

10.1111/J.1365-2362.2007.01781.X

21 January 2018

Identifiers

DOI

1 reference

5 April 2018

release_lt4b5tkt3bfdpg3xqeqlcagi2u

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/lt4b5tkt3bfdpg3xqeqlcagi2u

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

17373961

1 reference

5 April 2018